{"id":"pmc:PMC13704980","kind":"review","title":"Semaglutide, Other GLP-1 Receptor Agonists, and Papillary Thyroid Carcinoma: A Narrative Review of Risk, Progression, and Mechanisms","authors":["Barseghyan L","Munir I","Chrysafide S","Simental A","Khan S"],"author_count":5,"year":2026,"published":"2026-10-01","venue":"Journal of clinical medicine","cited_by":0,"doi":null,"arxiv_id":null,"nct_id":null,"source_url":"https://europepmc.org/article/PMC/PMC13704980","archive_url":"https://space-kitty.com/papers/pmc:PMC13704980","updated":null,"pmid":null,"pmcid":"PMC13704980","openalex_id":null,"pdf_url":"https://europepmc.org/articles/PMC13704980/pdf","abstract":null,"abstract_license":null,"license":"CC-BY","is_open_access":true,"peer_reviewed":null,"categories":[],"details":null,"provenance":"europepmc","attribution":"Metadata: Europe PMC (EMBL-EBI).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}